WO2006004696A3 - Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline - Google Patents
Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline Download PDFInfo
- Publication number
- WO2006004696A3 WO2006004696A3 PCT/US2005/022812 US2005022812W WO2006004696A3 WO 2006004696 A3 WO2006004696 A3 WO 2006004696A3 US 2005022812 W US2005022812 W US 2005022812W WO 2006004696 A3 WO2006004696 A3 WO 2006004696A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- insulin
- control
- compositions
- prevention
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05787795A EP1778266A4 (fr) | 2004-06-29 | 2005-06-27 | Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline |
MXPA06014970A MXPA06014970A (es) | 2004-06-29 | 2005-06-27 | Composiciones y metodos para la prevencion y el control de la hipoglucemia inducida por la insulina. |
CA002571030A CA2571030A1 (fr) | 2004-06-29 | 2005-06-27 | Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline |
AU2005260025A AU2005260025A1 (en) | 2004-06-29 | 2005-06-27 | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
JP2007519344A JP2008505087A (ja) | 2004-06-29 | 2005-06-27 | インスリン誘発性低血糖の予防および制御のための組成物ならびに方法 |
IL180361A IL180361A0 (en) | 2004-06-29 | 2006-12-26 | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
NO20070174A NO20070174L (no) | 2004-06-29 | 2007-01-10 | Preparater og fremgangsmater for forebyggelse og kontroll av insulindindusert hypoglykemi |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58444904P | 2004-06-29 | 2004-06-29 | |
US60/584,449 | 2004-06-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006004696A2 WO2006004696A2 (fr) | 2006-01-12 |
WO2006004696A3 true WO2006004696A3 (fr) | 2006-10-26 |
Family
ID=35783298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/022812 WO2006004696A2 (fr) | 2004-06-29 | 2005-06-27 | Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1778266A4 (fr) |
JP (1) | JP2008505087A (fr) |
KR (1) | KR20070029276A (fr) |
CN (1) | CN101001638A (fr) |
AU (1) | AU2005260025A1 (fr) |
CA (1) | CA2571030A1 (fr) |
IL (1) | IL180361A0 (fr) |
MX (1) | MXPA06014970A (fr) |
NO (1) | NO20070174L (fr) |
WO (1) | WO2006004696A2 (fr) |
ZA (1) | ZA200700708B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2533601T3 (es) | 2010-11-03 | 2015-04-13 | Arecor Limited | Nueva composición que comprende glucagón |
JP7001584B2 (ja) * | 2015-09-04 | 2022-01-19 | ラティチュード ファーマシューティカルズ インコーポレイテッド | 安定化されたグルカゴン溶液 |
GB201611077D0 (en) | 2016-06-24 | 2016-08-10 | Arecor Ltd | Novel composition |
CN110446496A (zh) * | 2017-02-03 | 2019-11-12 | 范德比尔特大学 | 用于治疗糖尿病的系统、组合物和方法 |
CA3069533A1 (fr) * | 2017-07-14 | 2019-01-17 | Xeris Pharmaceuticals, Inc. | Methodes de traitement d'hyperinsulinisme congenital |
WO2019108640A1 (fr) * | 2017-11-28 | 2019-06-06 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Procédés et kits pour évaluer le métabolisme |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5321008A (en) * | 1991-01-10 | 1994-06-14 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
US20040110817A1 (en) * | 2002-11-18 | 2004-06-10 | Pfizer Inc | Dipeptidyl peptidase IV inhibiting fluorinated cyclic amides |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3897551A (en) * | 1971-04-05 | 1975-07-29 | Lilly Co Eli | Iodoglucagons and process for prolonging the biological activity of glucagon |
US7314859B2 (en) * | 2002-12-27 | 2008-01-01 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
-
2005
- 2005-06-27 JP JP2007519344A patent/JP2008505087A/ja active Pending
- 2005-06-27 CN CNA2005800270476A patent/CN101001638A/zh active Pending
- 2005-06-27 WO PCT/US2005/022812 patent/WO2006004696A2/fr active Application Filing
- 2005-06-27 KR KR1020077002164A patent/KR20070029276A/ko not_active Application Discontinuation
- 2005-06-27 EP EP05787795A patent/EP1778266A4/fr not_active Withdrawn
- 2005-06-27 AU AU2005260025A patent/AU2005260025A1/en not_active Abandoned
- 2005-06-27 MX MXPA06014970A patent/MXPA06014970A/es not_active Application Discontinuation
- 2005-06-27 ZA ZA200700708A patent/ZA200700708B/xx unknown
- 2005-06-27 CA CA002571030A patent/CA2571030A1/fr not_active Abandoned
-
2006
- 2006-12-26 IL IL180361A patent/IL180361A0/en unknown
-
2007
- 2007-01-10 NO NO20070174A patent/NO20070174L/no not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5321008A (en) * | 1991-01-10 | 1994-06-14 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions |
US20040110817A1 (en) * | 2002-11-18 | 2004-06-10 | Pfizer Inc | Dipeptidyl peptidase IV inhibiting fluorinated cyclic amides |
Also Published As
Publication number | Publication date |
---|---|
ZA200700708B (en) | 2009-03-25 |
IL180361A0 (en) | 2007-06-03 |
MXPA06014970A (es) | 2007-03-07 |
WO2006004696A2 (fr) | 2006-01-12 |
JP2008505087A (ja) | 2008-02-21 |
AU2005260025A1 (en) | 2006-01-12 |
EP1778266A2 (fr) | 2007-05-02 |
CN101001638A (zh) | 2007-07-18 |
NO20070174L (no) | 2007-03-13 |
EP1778266A4 (fr) | 2009-09-09 |
KR20070029276A (ko) | 2007-03-13 |
CA2571030A1 (fr) | 2006-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05006994A (es) | Composiciones y metodos para la prevencion y el control de hipoglucemia inducida por insulina. | |
PH12018500767A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
WO2005020892A3 (fr) | Compositions pharmaceutiques et procedes de modulation metabolique | |
WO2007081824A3 (fr) | Protéines résistantes à la fibrillation | |
MX2013004699A (es) | Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos. | |
WO2007084314A3 (fr) | MODULATEURS de la 11-ß HYDROXYSTEROIDE DESHYDROGENASE DE TYPE 1, LEURS COMPOSITIONS PHARMACEUTIQUES ET LEURS PROCEDES D'UTILISATION | |
WO2008082602A3 (fr) | Composes et compositions pharmaceutiques destines au traitement des troubles hepatiques | |
WO2010092163A3 (fr) | Médicaments antidiabétiques | |
WO2007139941A3 (fr) | Composition et procédés de traitement de l'insuffisance cardiaque globale | |
WO2007128817A3 (fr) | Dérivé insulinique | |
WO2005009398A3 (fr) | Derives de benzamide tetracyclique et leurs procedes d'utilisation | |
MY173828A (en) | A composition for treating diabetes or diabesity comprising oxyntomodulin analog | |
WO2010030054A3 (fr) | Utilisations de dérivés de sesquiterpène | |
WO2008054695A3 (fr) | Composition et procédé pour le traitement étiologique et la prévention de maladies et/ou de complications associées à la déstabilisation chronique du métabolisme du glucose | |
WO2006004696A3 (fr) | Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline | |
WO2007018588A8 (fr) | Composition pharmaceutique stable comprenant la forme iv de linézolide | |
WO2010028132A3 (fr) | Nouveaux co-cristaux de choline et d'épalrestat | |
WO2009035534A3 (fr) | Traitement d'une maladie ischémique de l'œil par activation pharmaceutique systématique d'un facteur induit par l'hypoxie (hif) | |
WO2010011926A3 (fr) | Nouveau co-cristal de bétaïne d'épalrestat | |
AU2012207301A8 (en) | Apolipoprotein AIV as an antidiabetic peptide | |
EA200800338A1 (ru) | Профилактика и лечение офтальмологических осложнений диабета | |
WO2006133194A3 (fr) | Methodes permettant de traiter une infection virale a l'aide d'une solution medicamenteuse orale ou injectable | |
TW200633702A (en) | Medicinal composition containing fbpase inhibitor | |
WO2005039627A3 (fr) | Applications therapeutiques pour peptide c | |
AU2003212672A1 (en) | Pharmaceutical composition comprising an extract or compounds isolated from elfvingia applanata for the prevention and the treatment of diabetes and diabetic complications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/014970 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2571030 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007519344 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 180361 Country of ref document: IL |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005787795 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 258/KOLNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005260025 Country of ref document: AU Ref document number: 200700708 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 552860 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077002164 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580027047.6 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2005260025 Country of ref document: AU Date of ref document: 20050627 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005260025 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1020077002164 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2005787795 Country of ref document: EP |